Join us for an in-depth look at how biotechnology leaders are harnessing machine learning and data-driven approaches to engineer novel human therapeutics right now—well beyond the “someday” promises of AI. In this session, experts from pioneering organizations will share real-world insights into using big data and advanced analytics to accelerate everything from target discovery to clinical development. Discover how these teams are unlocking fresh possibilities for personalized treatments, improving success rates, and shaping the future of human health through powerful, actionable applications of ML and AI.